Economic evidence for the prevention and treatment of atopic eczema: A protocol for a systematic review

被引:6
|
作者
Sach T.H. [1 ]
McManus E. [1 ]
Mcmonagle C. [1 ]
Levell N. [2 ]
机构
[1] University of East Anglia, Health Economics Group, Norwich Medical School, Norwich
[2] Norfolk and Norwich University Hospitals NHS Foundation Trust, Dermatology Department, Colney Lane, Norwich
关键词
Cost effectiveness; Costs; Economics; Eczema; Health-related quality of life;
D O I
10.1186/s13643-016-0262-0
中图分类号
学科分类号
摘要
Background: Eczema, synonymous with atopic eczema or atopic dermatitis, is a chronic skin disease that has a similar impact on health-related quality of life as other chronic diseases. The proposed research aims to provide a comprehensive systematic assessment of the economic evidence base available to inform economic modelling and decision making on interventions to prevent and treat eczema at any stage of the life course. Whilst the Global Resource of Eczema Trials (GREAT) database collects together the effectiveness evidence for eczema, there is currently no such systematic resource on the economics of eczema. It is important to gain an overview of the current state of the art of economic methods in the field of eczema in order to strengthen the economic evidence base further. Methods/design: The proposed study is a systematic review of the economic evidence surrounding interventions for the prevention and treatment of eczema. Relevant search terms will be used to search MEDLINE, EMBASE, Database of Abstracts of Reviews of Effects, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, National Health Service (NHS) Economic Evaluation Database, Health Technology Assessment, Cumulative Index to Nursing and Allied Health Literature, EconLit, Scopus, Cost-Effectiveness Analysis Registry and Web of Science in order to identify relevant evidence. To be eligible for inclusion studies will be primary empirical studies evaluating the cost, utility or full economic evaluation of interventions for preventing or treating eczema. Two reviewers will independently assess studies for eligibility and perform data abstraction. Evidence tables will be produced presenting details of study characteristics, costing methods, outcome methods and quality assessment. The methodological quality of studies will be assessed using accepted checklists. Discussion: The systematic review is being undertaken to identify the type of economic evidence available, summarise the results of the available economic evidence and critically appraise the quality of economic evidence currently available to inform future economic modelling and resource allocation decisions about interventions to prevent or treat eczema. We aim to use the review to offer guidance about how to gather economic evidence in studies of eczema and/or what further research is necessary in order to inform this. Systematic review registration: PROSPERO CRD42015024633 © 2016 Sach et al.
引用
收藏
相关论文
共 50 条
  • [41] TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema
    Bosma, A. L.
    Spuls, P. I.
    Garcia-Doval, I.
    Naldi, L.
    Prieto-Merino, D.
    Tesch, F.
    Apfelbacher, C. J.
    Arents, B. W. M.
    Barbarot, S.
    Baselga, E.
    Deleuran, M.
    Eichenfield, L. F.
    Gerbens, L. A. A.
    Irvine, A. D.
    Manca, A.
    Mendes-Bastos, P.
    Middelkamp-Hup, M. A.
    Roberts, A.
    Seneschal, J.
    Svensson, A.
    Thyssen, J. P.
    Torres, T.
    Vermeulen, F. M.
    Vestergaard, C.
    von Kobyletzki, L. B.
    Wall, D.
    Weidinger, S.
    Schmitt, J.
    Flohr, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (06) : 1423 - 1429
  • [42] Dietary treatment of atopic eczema
    Kugler, C.
    ALLERGOLOGIE, 2011, 34 (03) : 159 - 167
  • [43] TREATMENT OF ITCHING IN ATOPIC ECZEMA
    BURKE, P
    BRITISH MEDICAL JOURNAL, 1989, 298 (6671): : 461 - 461
  • [44] Delirium prevention and treatment in the emergency department (ED): a systematic review protocol
    Dahlstrom, Elijah Blue
    Han, Jin Ho
    Healy, Heather
    Kennedy, Maura
    Arendts, Glenn
    Lee, Jacques
    Carpenter, Chris
    Lee, Sangil
    BMJ OPEN, 2020, 10 (10):
  • [45] What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 1: treatment and prevention
    Solman, L.
    Lloyd-Lavery, A.
    Grindlay, D. J. C.
    Rogers, N. K.
    Thomas, K. S.
    Harman, K. E.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (04) : 363 - 369
  • [46] What's new in atopic eczema? An analysis of systematic reviews published in 2015. Part 2: prevention and treatment
    Lloyd-Lavery, A.
    Rogers, N. K.
    Davies, E.
    Grindlay, D. J. C.
    Thomas, K. S.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2018, 43 (06) : 653 - 658
  • [47] What's new in atopic eczema? An analysis of systematic reviews published in 2017. Part 1: treatment and prevention
    Wernham, A. G. H.
    Veitch, D.
    Grindlay, D. J. C.
    Rogers, N. K.
    Harman, K. E.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (08) : 861 - 867
  • [48] Acupuncture for patients with atopic dermatitis A systematic review protocol
    Liu, Yijiang
    Cui, Hai
    Du, Ruosang
    Zhang, Lu
    Yuan, Hongwen
    Zhang, Xiaohui
    Zheng, Shumei
    MEDICINE, 2019, 98 (52)
  • [49] Recent advances in epidemiology and prevention of atopic eczema
    Cipriani, Francesca
    Dondi, Arianna
    Ricci, Giampaolo
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2014, 25 (07) : 630 - 638
  • [50] Probiotic supplementation for the prevention of eczema and allergic sensitisation: a systematic review
    Chivinge, J.
    Ierodiakonou, D.
    Leonardi-Bee, J.
    Garcia-Larsen, V.
    Boyle, R. J.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2015, 45 (02): : 534 - 534